@ARTICLE{
author={Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 18)},
year={2021},
title={Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results},
journal={AMERICAN JOURNAL OF HEMATOLOGY},
volume={96},
number={9},
pages={1156-1165},
document_type={Article},
} 

@ARTICLE{
author={Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 18)},
year={2017},
title={Outcomes after 18 months of eliglustat therapy in treatment-naive adults with Gaucher disease type 1: The phase 3 ENGAGE trial},
journal={AMERICAN JOURNAL OF HEMATOLOGY},
volume={92},
number={11},
pages={1170-1176},
document_type={Article},
} 

@ARTICLE{
author={Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 21)},
year={2015},
title={Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1 The ENGAGE Randomized Clinical Trial},
journal={JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION},
volume={313},
number={7},
pages={695-706},
document_type={Article},
}